Pei Y, Chan C, Cattran D, Cardella C, Zaltzman J, Lopez M, Tong J, Schachter R, Maurer J
Department of Medicine, Toronto Hospital, Ontario, Canada.
J Lab Clin Med. 1995 Jan;125(1):113-9.
Transient decreases in glomerular filtration rate (GFR) and renal plasma flow (RPF) have been associated with each daily dose of cyclosporine (CYA) in patients with renal allografts. We examined the differential dose effects of CYA on native renal function in 24 recipients of heart or lung transplants (treated with 7.3 +/- 0.5 mg/kg/day [mean +/- SEM]) and in seven patients with psoriasis (treated with 4.2 +/- 0.7 mg/kg/day). GFR and RPF were measured by urinary inulin and para-aminohippuric acid clearances 2 hours before the morning CYA dose and for 6 hours after. The age of heart and lung transplant recipients at renal study (2 months after transplantation) was 47 +/- 2.0 years. Their serum creatinine levels rose from 80 +/- 4.0 mumol/L during the first week after transplantation to 120 +/- 4.0 mumol/L at renal study (p < 0.0001). Their GFR and RPF were decreased before the CYA dose at 64 +/- 2.4 and 340 +/- 16 ml/min per 1.73 m2 and did not vary during the study. In comparison, the age of patients with psoriasis was 51 +/- 4.6 years at renal study (24 +/- 4.0 months after CYA treatment). Their serum creatinine levels rose from 80 +/- 4.0 mumol/L before treatment to 100 +/- 10 mumol/L at renal study (p = 0.07). Transient decreases of their baseline GFR and RPF (85 +/- 7.4 and 380 ml/min per 1.73 m2) with a nadir occurring during the first 2 hours of CYA ingestion were observed together with the recovery of these parameters toward baseline by the end of the study.(ABSTRACT TRUNCATED AT 250 WORDS)
肾移植患者中,每日服用环孢素(CYA)会导致肾小球滤过率(GFR)和肾血浆流量(RPF)短暂下降。我们研究了CYA对24例心脏或肺移植受者(接受7.3±0.5mg/kg/天[均值±标准误]治疗)和7例银屑病患者(接受4.2±0.7mg/kg/天治疗)的自身肾功能的不同剂量效应。在早晨服用CYA剂量前2小时及之后6小时,通过尿菊粉和对氨基马尿酸清除率测量GFR和RPF。肾脏研究时(移植后2个月),心脏和肺移植受者的年龄为47±2.0岁。他们的血清肌酐水平从移植后第一周的80±4.0μmol/L升至肾脏研究时的120±4.0μmol/L(p<0.0001)。服用CYA剂量前,他们的GFR和RPF降低,分别为64±2.4和340±16ml/分钟/1.73m²,研究期间无变化。相比之下,银屑病患者肾脏研究时(CYA治疗后24±4.0个月)的年龄为51±4.6岁。他们的血清肌酐水平从治疗前的80±4.0μmol/L升至肾脏研究时的100±10μmol/L(p = 0.07)。观察到他们的基线GFR和RPF(85±7.4和380ml/分钟/1.73m²)在服用CYA的前2小时出现短暂下降,最低点出现在此时,研究结束时这些参数恢复至基线水平。(摘要截断于250字)